"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 40 | 40 |
| 1996 | 0 | 47 | 47 |
| 1997 | 0 | 56 | 56 |
| 1998 | 0 | 55 | 55 |
| 1999 | 0 | 62 | 62 |
| 2000 | 0 | 60 | 60 |
| 2001 | 1 | 66 | 67 |
| 2002 | 0 | 97 | 97 |
| 2003 | 0 | 126 | 126 |
| 2004 | 1 | 123 | 124 |
| 2005 | 0 | 131 | 131 |
| 2006 | 0 | 136 | 136 |
| 2007 | 0 | 141 | 141 |
| 2008 | 0 | 204 | 204 |
| 2009 | 0 | 182 | 182 |
| 2010 | 0 | 195 | 195 |
| 2011 | 0 | 238 | 238 |
| 2012 | 0 | 252 | 252 |
| 2013 | 0 | 300 | 300 |
| 2014 | 0 | 300 | 300 |
| 2015 | 1 | 317 | 318 |
| 2016 | 0 | 346 | 346 |
| 2017 | 0 | 309 | 309 |
| 2018 | 0 | 369 | 369 |
| 2019 | 0 | 363 | 363 |
| 2020 | 0 | 322 | 322 |
| 2021 | 0 | 240 | 240 |
| 2022 | 0 | 70 | 70 |
| 2023 | 0 | 67 | 67 |
| 2024 | 0 | 249 | 249 |
| 2025 | 0 | 170 | 170 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR. Blood Adv. 2025 Nov 11; 9(21):5460-5472.
-
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28; 334(16):1442-1451.
-
Validating the California Verbal Learning Test-Second Edition-Short Form Forced Choice Trial as an Embedded Performance Validity Indicator. Arch Clin Neuropsychol. 2025 Oct 19; 40(7):1357-1365.
-
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. J Infect Dis. 2025 Oct 15; 232(4):e626-e636.
-
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenstr?m macroglobulinemia. Blood Adv. 2025 Oct 14; 9(19):4842-4847.
-
Patient and Caregiver Outcomes of Health System, Community-Based, and Usual Dementia Care: A Prespecified Analysis of the Dementia Care Study (D-CARE) Randomized Clinical Trial. JAMA Intern Med. 2025 Oct 01; 185(10):1227-1236.
-
Comparison of an image-guided system with four other devices for planning precise toric intraocular lens power calculation and axis alignment. J Cataract Refract Surg. 2025 Oct 01; 51(10):851-859.
-
Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenstr?m macroglobulinemia: a pooled analysis. Blood Adv. 2025 Sep 23; 9(18):4705-4715.
-
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenstr?m macroglobulinemia. Blood Adv. 2025 Sep 23; 9(18):4568-4579.
-
Bone quality response to lifestyle intervention in older adults with obesity (LIMB-Q trial): a randomised controlled trial. Lancet Healthy Longev. 2025 Sep; 6(9):100761.